Originally detected as a protein specifically expressed in stromal cells of invasive breast carcinomas [55], expression of MMP11 in breast cancer stroma has been associated with higher risk of invasive tumour growth and to correlate with worse clinical outcome in patients with invasive breast cancer, thereby potentially serving as prognostic factor [53, 54, 56, 57]. Here, MMP11 is linked to breast carcinoma.